Catalyst Wire Dossier Catalyst Wire Dossier

Sublingual immunotherapy tablet (house dust mite allergen extract)

house dust mite allergen extract tablet · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual immunotherapy tablet (house dust mite allergen extract), covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents [Phase 1]

See pricing